University of Exeter Medical School

Prof Anne Corbett

Prof Anne Corbett

Professor in Dementia Research

 A.M.J.Corbett@exeter.ac.uk

 4464

 +44 (0) 1392 724464

 College House 1.23

 

College House, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK

Overview

Prof Anne Corbett is Professor in Dementia Research and Director for Business Engagement and Innovation for the Department of Health and Community Sciences. Anne conducted her post-graduate PhD research at Imperial College in the field of molecular biology, infection and disease, giving her a grounding in molecular science and genetics. She then spent several years outside of academia working in research communications and implementation in the research team at Alzheimer’s Society UK. She returned to academia in 2011, applying her combined experience in basic science, dementia and translational research to dementia and ageing research. She spent four years at King’s College London where she developed a wide portfolio of dementia research ranging from online studies into risk reduction, drug discovery, clinical trials and care home research. She has particular expertise in clinical trial delivery, online research, translational research and patient and public involvement.

Anne’s research at the University of Exeter focuses on two broad areas. The first is cognitive health in ageing, which is built around a large online research cohort of people over 50, the PROTECT study, and an innovative digital platform that supports her research. She is involved with a wide portfolio of research in this field including clinical trials, longitudinal studies and novel approaches to cogntive monitoring for healthy ageing. Her second are is care home research, focusing on training, psychosocial and pharmacological approaches to improving the quality of dementia care in these settings.

Anne has published widely in the dementia research field, including over 130 peer reviewed publications, several book chapters on dementia and two best practice guidelines, one of which has been translated into eight languages and is in use worldwide. She holds funding from the National Institute of Health Research, Alzheimer’s Society, philanthropic donors and commercial partners.

Qualifications

  • PhD: Molecular microbiology and infection, Imperial College London (2008)
  • MRes: Infection and disease, Imperial College London (2005)
  • BSc: Biological Sciences, University of Bristol (2004)

Back to top

Research

Research interests

Anne’s research at the University of Exeter focuses on two broad areas. Firstly, Anne leads the large-scale online Platform for Research Online to Investigate Genetics and Cognition in Ageing (PROTECT) study [hyperlink: www.protectstudy.org.uk). PROTECT is a longitudinal cohort of over 25,000 people over 40 that seeks to explore the various genetic, lifestyle, environmental and medical factors involved in cognitive health and dementia risk in older adults. PROTECT is also an online clinical trials platform which has already delivered several large clinical trials, including a trial of brain training games in 9700 people, a remote, virtual trial of Vitamin D supplementation in 584 people and an intensive dietary supplementation trial in 60 people. Anne is developing this exciting portfolio of online ageing research including a series of nested studies including clinical trials and analysis of big data across a wide network of collaborators and partners and the development of digital infrastructure for trials delivery and cognitive monitoring technology.

Anne’s research also focuses on care home settings and dementia care. She has a particular interest in developing approaches that respond to the unique challenges and pressures that exist in care homes, and her work includes clinical trials, qualitative studies and reviews focusing on key care areas such as pain management, use of technology, staff training and nighttime care.

Lead Investigator Grants

  • Platform for Research Online Investigating Genetics and Cognition in Ageing (PROTECT) study (Multiple funders)

  • A Brain Training App for Cognition in people with Long Covid (BEACON) (NIHR RfPB 2023-2026)

  • Validation and commercialisation of a cognitive monitoring technology to improve assessment of cognition in older adults (ReaCTIVE) (NIHR i4i 2023-2028)

  • Improving night-time care for people with dementia in care homes through drug review and person-centred care: A cluster-randomised factorial trial (NightCAP)  Alzheimer's Society UK (2019 - 2023)

  • HealthyMinds Registry: An online clinical register for older adults in the US Synexus Ltd (2018 - 2023)

  • A randomised clinical trial of vitamin D to improve cognition in people at risk of dementia  JP Moulton Foundation (2020 - 2023)

  • Physical and cognitive correlates in older adults: Working towards an optimised physical activity intervention Wellcome Trust SeedCorn (2018 - 2019)

  • The impact of non-pharmacological treatment approaches for chronic joint pain in people with dementia living in care homes Graham Cole PhD Studentship (2017 – 20223)

  • Management of pain in people with dementia living in care homes NIHR PDG (2015 - 2017)
  • Sleep disturbance in people with dementia living in care homes: Development of a nighttime care package Alzheimer’s Society (2014 – 2017)
  • Can brain training lead to short term and sustained improvements in cognitive function? (Alzheimer’s Society) 2013 - 2017

Co-investigator Grants

  • Oral microbiome - dietary nitrate interactions and cognitive health in older age Tom Morgan (2021-2022)

  • Cognitive Testing for the Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes (SOUL)  Novo Nordisk (2019 – 2024)

  • Intervention Development for Alzheimer's Clinical Training (INTERACT) Alzheimer's Society  (2018 - 2021)

  • A systematic programme to develop and evaluate the best candidate treatments for repositioning in Alzheimer’s Disease (SMART-AD) (Wellcome Trust) 2014 - 2017
  • Supporting Excellence in End of Life care in Dementia (SEED) (NIHR PGfAR) 2013 - 2018
  • Goal-oriented cognitive rehabilitation in early-stage Alzheimer's disease: multi-centre single-blind randomised controlled trial (GREAT) (NIHR HTA) 2012 - 2016
  • An optimized intervention to reduce and treat behavioural symptoms in people with dementia living in care homes (WHELD) (NIHR PGfAR) 2011 - 201

Research projects

PROTECT Portfolio Studies

  • PROTECT longitudinal study: 25-year follow-up of cognition in older adults
  • PROTECT Genetics: Investigating the impact of genetic predictors of cognitive function in ageing
  • Can brain training lead to short-term and sustained improvements in cognitive function? Long-term engagement phase
  • Genetic predictors of treatment response to online brain training
  • Impact of short-term grammatical reasoning training on cognition in older adults
  • Impact of vitamin D supplementation on cognition in adults at risk of dementia
  • Impact of beetroot juice supplementation on oral microbiome and cognition in older adults
  • 60 ongoing and completed data analysis collaborations utilising PROTECT study data
  • PROTECT Study international francheses in Norway (PROTECT-Norge) and Canada (CAN-PROTECT)

Care Home Study Portfolio

  • Improving nighttime care for people with dementia in care homes through drug review and person-centred care (NIGHTCAP)
  • Management of pain in peopel with dementia in care homes (PhD Supervisor)
  • Use of digital technology to provide personalised pleasant activities for people with severe dementia in care homes (PhD supervisor)
  • Characterisation of the landscape of pain management in care homes: A qualitative study
  • Management of pain in people with dementia living in care homes: Intervention development and feasibility study
  • Mapping communication channels and barriers in care homes: A qualitative study
  • Sleep disturbance in people with dementia living in care homes: Development of a nighttime care package
  • Supporting Excellence in End of Life care in Dementia (SEED)
  • An optimized intervention to reduce and treat behavioural symptoms in people with dementia living in care homes (WHELD)
  • An eLearning Optimized Person Centred Intervention to Improve Staff Attitudes and Quality of Care for People with Dementia Living in Care Homes

Additional Studies:

  • A systematic programme to develop and evaluate the best candidate treatments for repositioning in Alzheimer’s Disease (SMART-AD)
  • Caregivers to people with different types of dementia (PhD Mentor, Stavanger University)
  • A randomised controlled feasibility trial evaluating the impact of an educational intervention regarding the treatment of hypertension for people with subcortical ischaemic vascular dementia (AFFECT EDUCATION) and their carers on treatment adherence and blood pressure  

Research grants

  • 2022 NIHR Research for Patient Benefit
    Online cognitive training for people with cognitive impairment following SARSCoV- 2 infection: A randomised controlled clinical trial
  • 2022 NIHR
    Clinical validation and commercialisation of the ReaCTIVE app: A proactive, interactive cognitive monitoring and intervention solution for people with early cognitive impairment
  • 2022 University of Calgary
    Canadian Platform for Research Online to Investigate Health, Quality of Life, Cognition, Behaviour, Function, and Caregiving in Aging (CAN-PROTECT)
  • 2022 Tom Morgan Foundation
    Oral microbiome - dietary nitrate interactions and cognitive health in older age
  • 2021 Tom Morgan Foundation
    Oral microbiome - dietary nitrate interactions and cognitive health in older age
  • 2021 Dunhill Medical Trust
    Understanding Developmental trajectories, and Inequalities in diagnosis and Treatment in adults aged 50 and over (AUDIT-50)
  • 2019 Alzheimers Society
    Improving night-time care and reducing hypnotic drug use in people with dementia living in care homes (NightCAP): A randomised factorial trial (£399,999)
  • 2019 Novo Nordisk
    Cognitive Testing for the Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes (SOUL)
  • 2018 JP Moulton Foundation
    A randomised clinical trial of vitamin D to improve cognition in people at risk of dementia
  • 2018 Synexus
    HealthyMinds Registry: An online clinical register for older adults in the US

Back to top

Publications

Journal articles

Corbett A, Creese B, Hayman V, Palmer A, Filakovsky A, Ballard C (In Press). Cognitive decline in older adults during and after the COVID-19 pandemic: a longitudinal analysis of the PROTECT UK study data. The Lancet Healthy Longevity
Sabatini S, Ukoumunne O, Ballard C, Collins R, Anstey K, Diehl M, Brothers A, Wahl H-W, Corbett A, Hampshire A, et al (In Press). Cross-Sectional Association between Objective Cognitive Performance and Perceived Age-related Gains and Losses in Cognition. International Psychogeriatrics
Sabatini S, Ukoumunne O, Brothers A, Diehl M, Wahl H-W, Clive B, Collins R, Corbett A, Brooker H, Clare L, et al (In Press). Differences in awareness of positive and negative age-related changes account for variability in health outcomes. European Journal of Ageing Abstract.
Ballard C, Brooker H, Corbett A, Ismail Z, Creese B, Wesnes K (In Press). FLAME: a computerized neuropsychological composite for trials in early dementia. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Wolfova K, Creese B, Aarsland D, Ismail Z, Corbett A, Ballard C, Hampshire A, Cermakova P (In Press). Gender/sex differences in the association of mild behavioral impairment with cognitive aging. Journal of Alzheimer's Disease
Wolfova K, Creese B, Aarsland D, Ismail Z, Corbett A, Ballard C, Hampshire A, Cermakova P (In Press). Gender/sex differences in the association of mild behavioral impairment with cognitive aging. Journal of Alzheimer's Disease
Creese B, Arathimos R, Brooker H, Aarsland D, Corbett A, Lewis C, Ballard C, Ismail Z (In Press). Genetic risk for Alzheimer’s disease, cognition and Mild Behavioral Impairment in healthy older adults. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Clare L, Kudlicka A, Oyebode JR, Jones RW, Bayer A, Leroi I, Kopelman M, James IA, Culverwell A, Pool J, et al (In Press). Goal-oriented cognitive Rehabilitation in Early-stage Alzheimer’s and related dementias: a multi-centre single-blind randomised controlled Trial (GREAT). Health Technology Assessment
Wang J, Spencer A, Hulme C, Corbett A, Khan Z, Vasconcelos Da Silva M, O'Dwyer S, Wright N, Testad I, Ballard C, et al (In Press). Healthcare utilisation and physical activities for older adults with comorbidities in the UK during COVID-19. Health and Social Care in the Community
Wang J, Spencer A, Hulme C, Khan Z, Vasconcelos Da Silva M, O'Dwyer S, Wright N, Testad I, Ballard C, Creese B, et al (In Press). Healthcare utilisation, physical activity and mental health during COVID-19 lockdown: an interrupted time-series analysis of older adults in England. European Journal of Ageing
Creese B, Arathimos R, Aarsland D, Ballard C, Brooker H, Hampshire A, Corbett A, Ismail Z (In Press). Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s disease. Alzheimer's and Dementia: Translational Research and Clinical Interventions
Arathimos R, Fabbri C, Vassos E, Davis KAS, Pain O, Gillett A, Coleman JRI, Hanscombe K, Hagenaars S, Jermy B, et al (In Press). Latent subtypes of manic and/or irritable episode symptoms in two 1 population-based cohorts. British Journal of Psychiatry
Lennon M, Brooker H, Creese B, Thayanandan T, Rigney G, Aarsland D, Hampshire A, Ballard C, Corbett A, Raymont V, et al (In Press). Lifetime TBI and cognitive domain deficits in late life: the PROTECT-TBI cohort study. Journal of Neurotrauma
Creese B, Khan Z, Henley W, O'Dwyer S, Corbett A, Vasconcelos Da Silva M, Mills K, Wright N, Testad I, Aarsland D, et al (In Press). Loneliness, physical activity and mental health during Covid-19: a longitudinal analysis of depression and anxiety in adults over 50 between 2015 and 2020. International Psychogeriatrics
Creese BA, Brooker H, Ismail Z, Wesnes K, Adam H, Khan Z, Maria M, Corbett A, Aarsland D, Ballard C, et al (In Press). Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults. American Journal of Geriatric Psychiatry
Rao R, Creese B, Aarsland D, Kalafatis C, Khan Z, Corbett A, Ballard C (In Press). Risky drinking and cognitive impairment in community residents. aged 50 and over. Aging and Mental Health
Allan L, Corbett A, Valderas Martinez J (In Press). Social prescribing programmes to prevent or delay frailty in community-dwelling older adults. Geriatrics
Sabatini S, Ukoumunne O, Ballard C, Collins R, Corbett A, Brooker H, Clare L (In Press). The Cross-sectional Relationship between Pain and Awareness of Age-Related Changes. British Journal of Pain
Stewart G, Corbett A, Ballard C, Creese B, Aarsland D, Hampshire A, Brooker H, Charlton R, Happe F (In Press). The cognitive profile of middle-aged and older adults with high vs. low autistic traits. Autism Research
Creese B, Corbett A, Ballard C (In Press). The mental and physical health of older adults with a genetic predisposition for autism. Autism Research: official journal of the International Society for Autism Research
McDermid J, Henley W, Corbett A, Williams G, Fossey J, Clare L, Fox C, Aarsland D, Khan Z, Soto M, et al (2024). Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: a randomized controlled trial. Alzheimers Dement, 20(3), 1797-1806. Abstract.  Author URL.
Akhanemhe R, Stevelink SAM, Corbett A, Ballard C, Brooker H, Creese B, Aarsland D, Hampshire A, Greenberg N (2024). Is lifetime traumatic brain injury a risk factor for mild cognitive impairment in veterans compared to non-veterans?. Eur J Psychotraumatol, 15(1). Abstract.  Author URL.
Vetere G, Williams G, Ballard C, Creese B, Hampshire A, Palmer A, Pickering E, Richards M, Brooker H, Corbett A, et al (2024). The relationship between playing musical instruments and cognitive trajectories: Analysis from a UK ageing cohort. Int J Geriatr Psychiatry, 39(2). Abstract.  Author URL.
Ballard C, Corbett A (2023). Antipsychotic drug presribing in dementia: changes from the pandemic. The Lancet Healthy Longevity, 4(8), e366-e367.
Ismail Z, Aarsland D, Ballard CG, Corbett A, Creese B (2023). Assessing risk taking and decision making associated with late‐life onset mild psychotics symptoms in cognitively normal older adults. Alzheimer's & Dementia, 19(S18).
O'Nions E, Petersen I, Buckman JEJ, Charlton R, Cooper C, Corbett A, Happé F, Manthorpe J, Richards M, Saunders R, et al (2023). Autism in England: assessing underdiagnosis in a population-based cohort study of prospectively collected primary care data. The Lancet Regional Health - Europe, 29, 100626-100626.
Sabatini S, Wilton-Harding B, Ballard C, Brooker H, Corbett A, Hampshire A, Windsor TD (2023). Bidirectional Associations of Awareness of Age-Related Change and Attitudes Toward Own Aging with Social Media Use. J Gerontol B Psychol Sci Soc Sci, 78(8), 1349-1359. Abstract.  Author URL.
Sabatini S, Cosentino S, Chapman S, Ballard C, Brooker H, Corbett A, Stephan BCM (2023). Cognitive trajectories: exploring the predictive role of subjective cognitive decline and awareness of age-related changes for cognitive functioning. Front Psychiatry, 14 Abstract.  Author URL.
McDermid J, Ballard C, Khan Z, Aarsland D, Fox C, Fossey J, Clare L, Moniz-Cook E, Soto-Martin M, Sweetnam A, et al (2023). Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings. Int J Geriatr Psychiatry, 38(1). Abstract.  Author URL.
Creese B, Gibbs O, Moodie E, Hampshire A, Corbett A, Ismail Z (2023). Late-life Onset Psychosis-like Symptoms Assessed in the Mild Behavioral Impairment Framework are Associated Impaired Performance on the Stroop Task. In&Vertebrates
Packer A, Corbett A, Arathimos R, Ballard C, Aarsland D, Hampshire A, Dima D, Creese B, Malanchini M, Powell TR, et al (2023). Limited evidence of a shared genetic relationship between C-reactive protein levels and cognitive function in older UK adults of European ancestry. Frontiers in Dementia, 2
Cousins O, Schubert JJ, Chandra A, Veronese M, Valkimadi P, Creese B, Khan Z, Arathimos R, Hampshire A, Rosenzweig I, et al (2023). Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge. J Neuroinflammation, 20(1). Abstract.  Author URL.
Testad I, Aakre JA, Ushakova A, Corbett A, Gjestsen MT, Aarsland D, Ballard CG (2023). PROTECT Norge: Online assessment of potentially modifiable risk factors for dementia on cognitive performance in a Norwegian ageing cohort. Alzheimer's & Dementia, 19(S8).
Sabatini S, Turner S, Brooker H, Ballard C, Corbett A, Hampshire A (2023). Physical and mental health conditions account for variability in awareness of age-related changes. Front Psychiatry, 14 Abstract.  Author URL.
Lancaster T, Creese B, Escott-Price V, Driver I, Menzies G, Khan Z, Corbett A, Ballard C, Williams J, Murphy K, et al (2023). Proof-of-concept recall-by-genotype study of extremely low and high Alzheimer's polygenic risk reveals autobiographical deficits and cingulate cortex correlates. Alzheimers Res Ther, 15(1). Abstract.  Author URL.
Sabatini S, Dritschel B, Rupprecht FS, Ukoumunne OC, Ballard C, Brooker H, Corbett A, Clare L (2023). Rumination moderates the longitudinal associations of awareness of age-related change with depressive and anxiety symptoms. Aging Ment Health, 27(9), 1711-1719. Abstract.  Author URL.
Stewart GR, Corbett A, Ballard C, Creese B, Aarsland D, Hampshire A, Charlton RA, Happé F (2023). Self-harm and Suicidality Experiences of Middle-Age and Older Adults with vs. Without High Autistic Traits. J Autism Dev Disord, 53(8), 3034-3046. Abstract.  Author URL.
Aakre JA, Schulz J, Ballard C, Corbett A, Bjorvatn B, Aarsland D, Creese B, Hampshire A, Brooker H, Testad I, et al (2023). Self-reported sleep fragmentation and sleep duration and their association with cognitive function in PROTECT, a large digital community-based cohort of people over 50. Int J Geriatr Psychiatry, 38(11). Abstract.  Author URL.
Sabatini S, Wahl H-W, Diehl M, Clare L, Ballard C, Brooker H, Corbett A, Hampshire A, Stephan BCM (2023). Testing Bidirectionality in Associations of Awareness of Age-Related Gains and Losses with Physical, Mental, and Cognitive Functioning Across 1 Year: the Role of Age. J Gerontol B Psychol Sci Soc Sci, 78(12), 2026-2036. Abstract.  Author URL.
Turner SG, Brooker H, Ballard C, Corbett A, Hampshire A, Sabatini S (2023). The Role of Awareness of Age-Related Change in the Longitudinal Association between Pain and Physical Activity. Int J Aging Hum Dev Abstract.  Author URL.
McDermid J, Da Silva MV, Williams G, Khan Z, Corbett A, Ballard C (2022). A Randomized Controlled Trial of a Digital Adaptation of the WHELD Person-Centered Nursing Home Training Program. J Am Med Dir Assoc, 23(7), 1166-1170. Abstract.  Author URL.
Singham T, Saunders R, Brooker H, Creese B, Aarsland D, Hampshire A, Ballard C, Corbett A, Desai R, Stott J, et al (2022). Are subtypes of affective symptoms differentially associated with change in cognition over time: a latent class analysis. J Affect Disord, 309, 437-445. Abstract.  Author URL.
Sabatini S, Martyr A, Ukoumunne OC, Ballard C, Collins R, Pentecost C, Rusted JM, Quinn C, Anstey KJ, Kim S, et al (2022). Attitudes toward own aging and cognition among individuals living with and without dementia: findings from the IDEAL programme and the PROTECT study. BMC Geriatrics, 22(1). Abstract.
Sabatini S, Ukoumunne OC, Brothers A, Diehl M, Wahl H-W, Ballard C, Collins R, Corbett A, Brooker H, Clare L, et al (2022). Differences in awareness of positive and negative age-related changes accounting for variability in health outcomes. Eur J Ageing, 19(4), 1087-1097. Abstract.  Author URL.
Sabatini S, Ukoumunne OC, Ballard C, Collins R, Corbett A, Brooker H, Clare L (2022). Exploring awareness of age-related changes among over 50s in the UK: findings from the PROTECT study. Int Psychogeriatr, 34(9), 789-803. Abstract.  Author URL.
Arathimos R, Fabbri C, Vassos E, Davis KAS, Pain O, Gillett A, Coleman JRI, Hanscombe K, Hagenaars S, Jermy B, et al (2022). Latent subtypes of manic and/or irritable episode symptoms in two population-based cohorts - ERRATUM. Br J Psychiatry, 1-2.  Author URL.
Geißler J, Isham E, Hickey G, Ballard C, Corbett A, Lubbert C (2022). Patient involvement in clinical trials. Commun Med (Lond), 2 Abstract.  Author URL.
Creese B, Aarsland D, Ballard CG, Brooker H, Corbett A, Ismail Z (2022). The association of the of late‐life onset psychotic symptoms with incident cognitive impairment in a cognitively normal sample. Alzheimer's & Dementia, 18(S7).
Stewart GR, Corbett A, Ballard C, Creese B, Aarsland D, Hampshire A, Charlton RA, Happé F (2022). Traumatic life experiences and post‐traumatic stress symptoms in middle‐aged and older adults with and without autistic traits. International Journal of Geriatric Psychiatry, 37(2).
Wilson KE, Corbett A, Van Horn A, Guevara Beltran D, Ayers JD, Alcock J, Aktipis A (2021). Associations Between Change over Time in Pandemic-Related Stress and Change in Physical Activity. J Phys Act Health, 18(11), 1419-1426. Abstract.  Author URL.
Sabatini S, Martyr A, Ukoumunne OC, Ballard C, Collins R, Pentecost C, Rusted JM, Quinn C, Anstey KJ, Kim S, et al (2021). Attitudes Toward Own Aging and Cognition among Individuals Living with and without Dementia: Findings from the IDEAL Programme and the PROTECT Study. Abstract.
Sabatini S, Ukoumunne O, Ballard C, Collins R, Corbett A, Brooker H, Clare L (2021). Cross-sectional and longitudinal associations between subjective sleep difficulties and self-perceptions of aging. Behavioral Sleep Medicine
Sabatini S, Ukoumunne O, Brothers A, Diehl M, Wahl H-W, Ballard C, Collins R, Corbett A, Brooker H, Clare L, et al (2021). Differences in Awareness of Positive and Negative Age-Related Changes Account for Variability in Health Outcomes. Abstract.
Ritchie S, Lawrence V, Jones J, Corbett A (2021). Engaging older adults in an online physical activity programme to improve cognition: a qualitative study. International Journal of Geriatric Psychiatry, 36(12), 1942-1949. Abstract.
Sun N, Ismail Z, Aarsland D, Brooker H, Corbett A, Ballard C, Creese B (2021). Examination of cognitive performance and mild behavioral impairment domains of apathy, mood, impulse dyscontrol, social inappropriateness and psychosis in cognitively normal adults aged 50 and over. Alzheimer's & Dementia, 17(S6).
Velayudhan L, French T, Ugochukwu A, Corbett A, Brooker H, Aarsland D, Ballard C, Proitsi P (2021). Hypertension, brain training and cognition in the healthy adults aged over 50 years: an online longitudinal study. Alzheimer's & Dementia, 17(S10).
Brooker H, Hayman V, Aarsland D, Creese B, Ballard C, Corbett A (2021). Impact of brisk walking on cognitive decline in adults with and without early impairment: a FLAME analysis in the PROTECT cohort. Alzheimer's & Dementia, 17(S10).
Arathimos R, Fabbri C, Vassos E, Davis KAS, Pain O, Gillett A, Coleman JRI, Hanscombe K, Hagenaars S, Jermy B, et al (2021). Latent subtypes of manic or irritable episode symptoms in two population-based cohorts. Abstract.
Roheger M, Kalbe E, Corbett A, Brooker H, Ballard C (2021). Predictors of activities of daily living in heathy older adults: Who benefits most from online cognitive training?. Brain Behav, 11(11). Abstract.  Author URL.
Lennon MJ, Thayanandan T, Corbett A, Aarsland D, Ballard C, Raymont V (2021). Repeated concussions associated with worsened working memory, attention and processing speed, but preserved delayed memory: a PROTECT study. Alzheimer's & Dementia, 17(S10).
Creese B, Arathimos R, Brooker H, Corbett A, Aarsland D, Lewis C, Ballard C, Ismail Z (2021). Self and informant‐rated mild behavioral impairment and genetic risk for AD: the respondent matters. Alzheimer's & Dementia, 17(S6).
Turner S, Sabatini S, Brooker H, Corbett A, Hampshire A (2021). Self-Perceptions of Aging Among Dementia Caregivers: Evidence from the UK Protect Study. Innovation in Aging, 5(Suppl 1), 603-604.
Wolfova K, Creese B, Aarsland D, Ismail Z, Corbett A, Ballard C, Hampshire A, Cermakova P (2021). Sex differences in the association of mild behavioral impairment with cognitive aging. Abstract.
Stewart GR, Corbett A, Ballard C, Creese B, Aarsland D, Hampshire A, Charlton RA, Happé F (2021). The Mental and Physical Health Profiles of Older Adults Who Endorse Elevated Autistic Traits. J Gerontol B Psychol Sci Soc Sci, 76(9), 1726-1737. Abstract.  Author URL.
Brooker H, Hayman V, Aarsland D, Creese B, Ballard C, Corbett A (2021). The impact of the COVID‐19 pandemic on cognitive health. Alzheimer's & dementia : the journal of the Alzheimer's Association, 17(Suppl 10). Abstract.
Brooker H, Hayman V, Aarsland D, Creese B, Ballard C, Corbett A (2021). The impact of the COVID‐19 pandemic on cognitive health. Alzheimer's & Dementia, 17(Suppl 10).
Sabatini S, Ukoumunne OC, Ballard C, Collins R, Kim S, Corbett A, Aarsland D, Hampshire A, Brooker H, Clare L, et al (2021). What does feeling younger or older than one’s chronological age mean to men and women? Qualitative and quantitative findings from the PROTECT study. Psychology & Health, 38(3), 324-347.
Ballard C, Corbett A, Aarsland D, Cummings J, O'Brien J, Mills R, Molinuevo JL, Fladby T, Wiliams G, Doherty P, et al (2020). Drug repositioning and repurposing. for Alzheimer disease. Nature Reviews Neurology
Creese B, Brooker H, Aarsland D, Corbett A, Ballard C, Ismail Z (2020). Genetic risk for Alzheimer disease, cognition and Mild Behavioral Impairment in healthy older adults. Abstract.
Sabatini S, Ukoumunne O, Ballard C, Collins R, Anstey KJ, Diehl M, Brothers A, Corbett A, Hampshire A, Brooker H, et al (2020). Higher perceived age‐related gains and losses relate to lower objective cognitive scores. Alzheimer's & Dementia, 16(S6).
Ballard C, Orrell M, Moniz-Cook E, Woods R, Whitaker R, Corbett A, Aarsland D, Murray J, Lawrence V, Testad I, et al (2020). Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs. Programme Grants for Applied Research, 8(6), 1-98. Abstract.
sabatini S, Ukoumunne OC, Ballard C, Brothers A, Kaspar R, Collins R, Kim S, Corbett A, Aarsland D, Hampshire A, et al (2020). International relevance of Two Measures of Awareness of Age-Related Change (AARC). Abstract.
Sabatini S, Ukoumunne O, Ballard C, Brothers A, Kaspar R, Collins R, Kim S, Corbett A, Aarsland D, Hampshire A, et al (2020). International relevance of Two Measures of Awareness of Age-Related Change (AARC). BMC Geriatrics, 20
Sabatini S, Ukoumunne OC, Ballard C, Brothers A, Kaspar R, Collins R, Kim S, Corbett A, Aarsland D, Hampshire A, et al (2020). International relevance of Two Measures of Awareness of Age-Related Change (AARC). Abstract.
Roheger M, Kalbe E, Corbett A, Brooker H, Ballard C (2020). Lower cognitive baseline scores predict cognitive training success after 6 months in healthy older adults: Results of an online <scp>RCT</scp>. International Journal of Geriatric Psychiatry, 35(9), 1000-1008. Abstract.
Roheger M, Kalbe E, Corbett A, Brooker H, Ballard C (2020). Predictors of changes after reasoning training in healthy adults. Brain and Behavior, 10(12). Abstract.
Ballard C, Corbett A (2020). Reducing psychotropic drug use in people with dementia living in nursing homes. International Psychogeriatrics, 32(3), 291-294.
Creese B, Brooker H, Aarsland D, Corbett A, Ballard C, Ismail Z (2020). Relationship between genetic risk for Alzheimer's, cognition and neuropsychiatric symptoms: a case study of DNA sampling and analysis through digital platform cohort studies. Alzheimer's & Dementia, 16(S10).
Stewart GR, Corbett A, Ballard C, Creese B, Aarsland D, Hampshire A, Charlton RA, Happé F (2020). Sleep problems and mental health difficulties in older adults who endorse high autistic traits. Research in Autism Spectrum Disorders, 77 Abstract.
Robinson L, Poole M, McLellan E, Lee R, Amador S, Bhattarai N, Bryant A, Coe D, Corbett A, Exley C, et al (2020). Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT. Programme Grants for Applied Research, 8(8), 1-254. Abstract.
Desai R, Charlesworth GM, Brooker HJ, Potts HWW, Corbett A, Aarsland D, Ballard CG (2020). Temporal Relationship Between Depressive Symptoms and Cognition in Mid and Late Life: a Longitudinal Cohort Study. Journal of the American Medical Directors Association, 21(8), 1108-1113. Abstract.
Bauermeister S, Orton C, Thompson S, Barker RA, Bauermeister JR, Ben-Shlomo Y, Brayne C, Burn D, Campbell A, Calvin C, et al (2020). The Dementias Platform UK (DPUK) Data Portal. Eur J Epidemiol, 35(6), 601-611. Abstract.  Author URL.
Brooker H, Wesnes KA, Ballard C, Hampshire A, Aarsland D, Khan Z, Stenton R, McCambridge L, Corbett A (2019). An online investigation of the relationship between the frequency of word puzzle use and cognitive function in a large sample of older adults. Int J Geriatr Psychiatry, 34(7), 921-931. Abstract.  Author URL.
Ballard C, Corbett A (2019). Commentary: Opportunities for Combination Trials. J Prev Alzheimers Dis, 6(3), 177-178.  Author URL.
Newman L, Stoner C, Corbett A, Megalogeni M, Khan Z, Spector A (2019). Development of the ‘SNS older adults measure’ (SNS-OA) to examine social network site use in older adults. Aging & Mental Health, 25(1), 68-77.
Ballard C, Creese B, Gatt A, Doherty P, Francis PT, Whitfield D, Corbett A, Corcoran J, Hanger D, Thuret S, et al (2019). Identifying Novel Candidates for Re-Purposing as Potential Therapeutic Agents for Alzheimer’s disease. Abstract.
Eraydin IE, Mueller C, Corbett A, Ballard C, Brooker H, Wesnes K, Aarsland D, Huntley J (2019). Investigating the relationship between age of onset of depressive disorder and cognitive function. Int J Geriatr Psychiatry, 34(1), 38-46. Abstract.  Author URL.
Testad I, Kajander M, Froiland CT, Corbett A, Gjestsen MT, Anderson JG (2019). Nutritional Interventions for Persons with Early-Stage Dementia or Alzheimer's Disease: an Integrative Review. Res Gerontol Nurs, 12(5), 259-268. Abstract.  Author URL.
Brooker H, Ballard C, Aarsland D, Khan Z, Wesnes K, Corbett A (2019). P1‐459: INFORMANT‐ AND PARTICIPANT‐REPORTED COGNITIVE FUNCTION USING THE IQCODE MEASURE IS a ROBUST INDICATOR OF COGNITIVE HEALTH. Alzheimer's & Dementia, 15(7S_Part_8), p443-p444.
Creese B, Brooker H, Wesnes K, Corbett A, Aarsland D, Ismail Z, Ballard C (2019). P1‐468: CHARACTERISING THE COGNITIVE PROFILE ASSOCIATED WITH INDIVIDUAL DOMAINS OF MID BEHAVIOURAL IMPAIRMENT IN THE COGNITIVELY NORMAL POPULATION. Alzheimer's & Dementia, 15(7S_Part_8), p447-p448.
Brooker H, Ballard C, Aarsland D, Khan Z, Wesnes K, Corbett A (2019). P2‐584: ASSOCIATION OF SELF‐REPORTED PHYSICAL EXERCISE FREQUENCY AND COGNITIVE TRAJECTORY IN OLDER ADULTS. Alzheimer's & Dementia, 15(7S_Part_16), p847-p847.
Brooker H, Severin J, Sander M, Corbett A, Aarsland D, Wesnes K, Ballard C (2019). P2‐607: USE OF HEARING AIDS IN OLDER ADULTS WITH HEARING LOSS IS ASSOCIATED WITH IMPROVED COGNITIVE TRAJECTORY. Alzheimer's & Dementia, 15(7S_Part_16), p857-p858.
Creese B, Brooker H, Corbett A, Aarsland D, Ballard C (2019). P3‐319: FAMILY HISTORY OF DEMENTIA WITH PSYCHOTIC SYMPTOMS IN THE COGNITIVELY NORMAL POPULATION: FEASIBILITY OF MEASUREMENT AND INITIAL CLINICAL AND GENETIC ASSOCIATIONS. Alzheimer's & Dementia, 15(7S_Part_20), p1059-p1059.
Corbett A, Brooker H, Aarsland D, Wesnes K, Ballard C (2019). P3‐484: CHRONIC PAIN IS ASSOCIATED WITH POOR COGNITIVE TRAJECTORY IN OLDER ADULTS. Alzheimer's & Dementia, 15(7S_Part_22), p1153-p1153.
Velayudhan L, Ugochukwu A, Wesnes K, Brooker H, Corbett A, Aarsland D, Ballard C, Proitsi P (2019). P3‐555: AN ONLINE ASSESSMENT OF THE INFLUENCE OF VASCULAR RISK FACTORS ON COGNITIVE FUNCTION IN HEALTHY ADULTS AGED 50 AND ABOVE. Alzheimer's & Dementia, 15(7S_Part_22), p1187-p1187.
Creese B, Brooker H, Corbett A, Ismail Z, Aarsland D, Ballard C (2019). P4‐248: EVALUATING SHARED GENETIC LIABILITY FOR LATE‐LIFE ABNORMAL THOUGHTS AND PERCEPTION (MILD BEHAVIORAL IMPAIRMENT), AND NEUROLOGICAL AND PSYCHIATRIC CONDITIONS. Alzheimer's & Dementia, 15(7S_Part_26), p1374-p1374.
Corbett A, Slowinski P, Ballard C, Aarsland D, Wesnes K, Brooker H (2019). P4‐428: COGNITIVE TRAJECTORIES OF HEALTHY OLDER ADULTS OVER THREE YEARS: a LARGE‐SCALE LONGITUDINAL ANALYSIS. Alzheimer's & Dementia, 15(7S_Part_28), p1466-p1467.
Corbett A, Brooker H, Hampshire A, Williams G, Wesnes K, Aarsland D, Ballard C (2019). P4‐658: INTENSIVE SHORT‐TERM ONLINE COGNITIVE TRAINING IN GRAMMATICAL REASONING CONFERS BENEFITS TO COGNITION AND FUNCTION IN OLDER ADULTS: OUTCOMES FROM THE START RANDOMISED CONTROLLED TRIAL. Alzheimer's & Dementia, 15(7S_Part_30), p1583-p1583.
Creese BA, Griffiths A, Brooker H, Corbett A, Aarsland D, Ballard C, Ismail Z (2019). Profile of Mild Behavioral Impairment and Factor Structure of the Mild Behavioral Impairment Checklist in Cognitively Normal Older Adults. International Psychogeriatrics
Creese B, Griffiths A, Brooker H, Corbett A, Aarsland D, Ballard C, Ismail Z (2019). Profile of mild behavioral impairment and factor structure of the Mild Behavioral Impairment Checklist in cognitively normal older adults. International Psychogeriatrics, 32(6), 705-717. Abstract.
Bauermeister S, Orton C, Thompson S, Barker RA, Bauermeister JR, Ben-Shlomo Y, Brayne C, Burn D, Campbell A, Calvin C, et al (2019). The Dementias Platform UK (DPUK) Data Portal. Abstract.
Brooker H, Wesnes KA, Ballard C, Hampshire A, Aarsland D, Khan Z, Stenton R, Megalogeni M, Corbett A (2019). The relationship between the frequency of number-puzzle use and baseline cognitive function in a large online sample of adults aged 50 and over. Int J Geriatr Psychiatry, 34(7), 932-940. Abstract.  Author URL.
sabatini S, Ukoumunne O, Ballard C, Brothers A, Kaspar R, Collins R, Kim S, Corbett A, Aarsland D, Hampshire A, et al (2019). UK Validation of Two Measures of Awareness of Age-Related Change (AARC). Abstract.
Corbett A, Gordon C (2018). Academic Freedom in Europe: the Central European University Affair and the Wider Lessons. HISTORY OF EDUCATION QUARTERLY, 58(3), 467-474.  Author URL.
Lane CA, Hardy J, Schott JM (2018). Alzheimer's disease. EUROPEAN JOURNAL OF NEUROLOGY, 25(1), 59-70.  Author URL.
Nunez KM, Khan Z, Testad I, Lawrence V, Creese B, Corbett A (2018). Current practice and challenges in night-time care for people with dementia living in care homes: a qualitative study. Int J Geriatr Psychiatry, 33(1), e140-e149. Abstract.  Author URL.
Petyaeva A, Kajander M, Lawrence V, Clifton L, Thomas AJ, Ballard C, Leroi I, Briggs M, Closs J, Dening T, et al (2018). Feasibility of a staff training and support programme to improve pain assessment and management in people with dementia living in care homes. Int J Geriatr Psychiatry, 33(1), 221-231. Abstract.  Author URL.
Ballard C, Corbett A, Orrell M, Williams G, Moniz-Cook E, Romeo R, Woods B, Garrod L, Testad I, Woodward-Carlton B, et al (2018). Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: a cluster-randomised controlled trial. PLoS Med, 15(2). Abstract.  Author URL.
Huntley J, Corbett A, Wesnes K, Brooker H, Stenton R, Hampshire A, Ballard C (2018). Online assessment of risk factors for dementia and cognitive function in healthy adults. Int J Geriatr Psychiatry, 33(2), e286-e293. Abstract.  Author URL.
Creese B, Bergh S, Aarsland D, Andersen F, Brooker H, Corbett A, Khan Z, Megalogeni M, Rongve A, Stordal E, et al (2018). P1‐151: GENETIC OVERLAP BETWEEN PSYCHOTIC SYMPTOMS ACROSS THE LIFESPAN: FINDINGS FROM SCHIZOPHRENIA, COGNITIVELY NORMAL OLDER ADULTS AND ALZHEIMER'S DISEASE. Alzheimer's & Dementia, 14(7S_Part_6).
Brooker H, Creese B, Ismail Z, Khan Z, Megalogeni M, Corbett A, Hampshire A, Aarsland D, Ballard C, Wesnes K, et al (2018). P1‐523: THE RELATIONSHIP BETWEEN THE MILD BEHAVIOURAL IMPAIRMENT CHECKLIST (MBI‐C) TOTAL SCORE AND CORE ASPECTS OF COGNITIVE FUNCTION IN OLDER ADULTS. Alzheimer's & Dementia, 14(7S_Part_9).
Ballard C, Brooker H, Khan Z, Corbett A, Aarsland D, Wesnes K (2018). P1‐658: REPEATED COGNITIVE TESTING REDUCES SAMPLE SIZE NECESSARY TO DETECT CLINICALLY RELEVANT EFFECTS. Alzheimer's & Dementia, 14(7S_Part_10), p595-p595.
Wesnes K, Brooker H, Creese B, Khan Z, Megalogeni M, Corbett A, Davis K, Hotopf M, Aarsland D, Ballard C, et al (2018). P2‐483: DEPRESSION IS ASSOCIATED WITH IMPAIRMENT IN COGNITIVE FUNCTION IN ADULTS AGED 50 AND OVER. Alzheimer's & Dementia, 14(7S_Part_16).
Creese B, Brooker H, Ismail Z, Aarsland D, Corbett A, Khan Z, Megalogeni M, Ballard C, Wesnes K (2018). P3‐554: PROFILE OF MILD BEHAVIOURAL IMPAIRMENT IN a POPULATION‐BASED SAMPLE OF ADULTS AGED 50 AND OVER: INITIAL FINDINGS FROM THE PROTECT STUDY. Alzheimer's & Dementia, 14(7S_Part_25).
Svendsboe EJ, Testad I, Terum T, Jörg A, Corbett A, Aarsland D, Rongve A (2018). Patterns of carer distress over time in mild dementia. Int J Geriatr Psychiatry, 33(7), 987-993. Abstract.  Author URL.
Austbø Holteng LB, Frøiland CT, Corbett A, Testad I (2017). Care staff perspective on use of texture modified food in care home residents with dysphagia and dementia. Ann Palliat Med, 6(4), 310-318. Abstract.  Author URL.
Svendsboe E, Terum T, Testad I, Aarsland D, Ulstein I, Corbett A, Rongve A (2017). Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease (vol 31, pg 1075, 2016). INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 32(4), 470-470.  Author URL.
Khan A, Corbett A, Ballard C (2017). Emerging amyloid and tau targeting treatments for Alzheimer's disease. Expert Rev Neurother, 17(7), 697-711. Abstract.  Author URL.
Khan A, Corbett A, Ballard C (2017). Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets. Expert Rev Neurother, 17(7), 683-695. Abstract.  Author URL.
Rajkumar AP, Ballard C, Fossey J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Whitaker R, Stafford J, Knapp M, et al (2017). Epidemiology of Pain in People with Dementia Living in Care Homes: Longitudinal Course, Prevalence, and Treatment Implications. J Am Med Dir Assoc, 18(5), 453.e1-453.e6. Abstract.  Author URL.
Drageset J, Eide GE, Corbett A (2017). Health-related quality of life among cognitively intact nursing home residents with and without cancer - a 6-year longitudinal study. Patient Relat Outcome Meas, 8, 63-69. Abstract.  Author URL.
Mueller C, Ballard C, Corbett A, Aarsland D (2017). Historical landmarks in dementia with Lewy bodies. Lancet Neurol, 16(5).  Author URL.
Ballard C, Orrell M, Sun Y, Moniz-Cook E, Stafford J, Whitaker R, Woods B, Corbett A, Banerjee S, Testad I, et al (2017). Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial. Int J Geriatr Psychiatry, 32(10), 1094-1103. Abstract.  Author URL.
Gatt A, Ekonomou A, Somani A, Thuret S, Howlett D, Corbett A, Johnson M, Perry E, Attems J, Francis P, et al (2017). Importance of Proactive Treatment of Depression in Lewy Body Dementias: the Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study. Dement Geriatr Cogn Disord, 44(5-6), 283-293. Abstract.  Author URL.
Flo E, Bjorvatn B, Corbett A, Pallesen S, Husebo BS (2017). Joint Occurrence of Pain and Sleep Disturbances in People with Dementia. A Systematic Review. Curr Alzheimer Res, 14(5), 538-545. Abstract.  Author URL.
Mueller C, Ballard C, Corbett A, Aarsland D (2017). The prognosis of dementia with Lewy bodies. Lancet Neurol, 16(5), 390-398. Abstract.  Author URL.
Wesnes KA, Brooker H, Ballard C, McCambridge L, Stenton R, Corbett A (2017). Utility, reliability, sensitivity and validity of an online test system designed to monitor changes in cognitive function in clinical trials. Int J Geriatr Psychiatry, 32(12), e83-e92. Abstract.  Author URL.
Ballard C, Fossey J, Corbett A, Orrell M, Romeo R, Moniz‐Cook E, Woods B, Whitaker R (2017). [F1–01–01]: IMPACT OF WHELD INTERVENTION ON NEUROPSYCHIATRIC SYMPTOMS, ANTIPSYCHOTIC USE AND QUALITY OF LIFE IN PEOPLE WITH DEMENTIA LIVING IN NURSING HOMES: a CLUSTER‐RANDOMIZED TRIAL. Alzheimer's & Dementia, 13(7S_Part_3), p171-p171.
Clare L, Kudlicka A, Bayer A, Jones RW, John Knapp MR, Kopelman M, Leroi I, Oyebode J, Pool J, Woods B, et al (2017). [O3–02–05]: GOAL‐ORIENTED COGNITIVE REHABILITATION IN EARLY‐STAGE ALZHEIMER's AND RELATED DEMENTIAS: RESULTS FROM a MULTI‐CENTRE, SINGLE‐BLIND, RANDOMISED CONTROLLED TRIAL (THE GREAT TRIAL). Alzheimer's & Dementia, 13(7S_Part_18).
Rajamani APR, Ballard C, Fossey J, Orrell M, Moniz‐Cook E, Woods R, Murray J, Whitaker R, Stafford J, Knapp MRJ, et al (2017). [P1–562]: EPIDEMIOLOGY OF PAIN IN PEOPLE WITH DEMENTIA LIVING IN CARE HOMES: LONGITUDINAL COURSE, PREVALENCE AND TREATMENT IMPLICATIONS. Alzheimer's & Dementia, 13(7S_Part_10), p509-p510.
Corbett A, Ballard C, Brooker H, Hampshire A, Stenton R, McCambridge L, Wesnes K (2017). [P1–599]: ONLINE COGNITIVE TRAINING INCREASES NEUROGENESIS AND IMPROVES COGNITIVE PERFORMANCE IN ADULTS OVER 50. Alzheimer's & Dementia, 13(7S_Part_10), p525-p525.
Brooker H, Wesnes K, McCambridge L, Ballard C, Corbett A (2017). [P1–612]: THE RELATIONSHIP BETWEEN SELF‐REPORTED MONTHLY PHYSICAL EXERCISE FREQUENCY AND COGNITIVE FUNCTION. Alzheimer's & Dementia, 13(7S_Part_10), p531-p531.
Wesnes K, Brooker H, Corbett A, McCambridge L, Ballard C (2017). [P1–614]: THE ASSOCIATION BETWEEN COGNITIVE FUNCTION AND ACTIVITIES OF DAILY LIVING IN HEALTHY ADULTS AGED 50 AND OVER. Alzheimer's & Dementia, 13(7S_Part_10), p532-p532.
Wesnes K, Brooker H, Corbett A, McCambridge L, Ballard C (2017). [P2–581]: THE RELATIONSHIP BETWEEN THE FREQUENCY OF WORD PUZZLE USE AND COGNITIVE FUNCTION IN a LARGE SAMPLE OF ADULTS AGED 50 TO 96 YEARS. Alzheimer's & Dementia, 13(7S_Part_17).
Huntley JD, Corbett A, Wesnes K, Hampshire A, Ballard C (2017). [P3–563]: RISK FACTORS FOR DEMENTIA AND COGNITIVE FUNCTION IN HEALTHY ADULTS. Alzheimer's & Dementia, 13(7S_Part_24), p1194-p1195.
Wesnes K, Brooker H, Corbett A, Ballard C (2017). [P3–582]: CAN INCREASING THE DIFFICULTY OF A NEUROGENESIS‐SENSITIVE TASK ENHANCE ITS SENSITIVITY TO DETECTING AGE‐RELATED DECLINES IN VOLUNTEERS AGED 50 TO 96?. Alzheimer's & Dementia, 13(7S_Part_25).
Greenan C, Murphy L, Yu L-M, Kehoe PG, Coulthard E, Bath P, Stewart R, Jones R, Corbett A, Thomas A, et al (2016). A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine for the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol. Trials, 17(1). Abstract.  Author URL.
Rajkumar AP, Ballard C, Fossey J, Corbett A, Woods B, Orrell M, Prakash R, Moniz-Cook E, Testad I (2016). Apathy and its Response to Antipsychotic Review and Nonpharmacological Interventions in People with Dementia Living in Nursing Homes: WHELD, a Factorial Cluster Randomized Controlled Trial. Journal of the American Medical Directors Association, 17(8), 741-747. Abstract.
Svendsboe E, Terum T, Testad I, Aarsland D, Ulstein I, Corbett A, Rongve A (2016). Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry, 31(9), 1075-1083. Abstract.  Author URL.
Ballard C, Mobley W, Hardy J, Williams G, Corbett A (2016). Dementia in Down's syndrome. Lancet Neurol, 15(6), 622-636. Abstract.  Author URL.
Corbett A, Ballard C (2016). Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches. Evid Based Med, 21(1).  Author URL.
Surr CA, Walwyn REA, Lilley-Kelly A, Cicero R, Meads D, Ballard C, Burton K, Chenoweth L, Corbett A, Creese B, et al (2016). Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial. Trials, 17(1). Abstract.  Author URL.
Ballard C, Orrell M, YongZhong S, Moniz-Cook E, Stafford J, Whittaker R, Woods B, Corbett A, Garrod L, Khan Z, et al (2016). Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People with Dementia Living in Nursing Homes: a Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People with Dementia (WHELD) Program. Am J Psychiatry, 173(3), 252-262. Abstract.  Author URL.
Mills R, Ballard C, Isaacson S, Williams H, Corbett A, Coate B, Pahwa R, Rascol O, Burn D (2016). Impact of current antipsychotic medications on comparative mortality and adverse events in people with Parkinson’s disease psychosis (PDP). Parkinsonism & Related Disorders, 22, e91-e92.
Lichtner V, Dowding D, Allcock N, Keady J, Sampson EL, Briggs M, Corbett A, James K, Lasrado R, Swarbrick C, et al (2016). The assessment and management of pain in patients with dementia in hospital settings: a multi-case exploratory study from a decision making perspective. BMC Health Serv Res, 16(1). Abstract.  Author URL.
Corbett A, Nunez K-M, Smeaton E, Testad I, Thomas AJ, Closs SJ, Briggs M, Clifton L, Gjestsen MT, Lawrence V, et al (2016). The landscape of pain management in people with dementia living in care homes: a mixed methods study. Int J Geriatr Psychiatry, 31(12), 1354-1370. Abstract.  Author URL.
Closs SJ, Dowding D, Allcock N, Hulme C, Keady J, Sampson EL, Briggs M, Corbett A, Esterhuizen P, Holmes J, et al (2016). Towards improved decision support in the assessment and management of pain for people with dementia in hospital: a systematic meta-review and observational study. Health Services and Delivery Research, 4(30), 1-162. Abstract.
Khan A, Kalaria RN, Corbett A, Ballard C (2016). Update on Vascular Dementia. J Geriatr Psychiatry Neurol, 29(5), 281-301. Abstract.  Author URL.
Ballard C, Thomas A, Gerry S, Yu L-M, Aarsland D, Merritt C, Corbett A, Davison C, Sharma N, Khan Z, et al (2015). A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People with Alzheimer's Disease (MAIN-AD). JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 16(4), 316-322.  Author URL.
Ferreira N, Owen A, Mohan A, Corbett A, Ballard C (2015). Associations between cognitively stimulating leisure activities, cognitive function and age-related cognitive decline. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 30(4), 422-430.  Author URL.
Ballard C, Sharp S, Corbett A (2015). Dextromethorphan and Quinidine for Treating Agitation in Patients with Alzheimer Disease Dementia. JAMA, 314(12), 1233-1235.  Author URL.
Corbett A (2015). Drug repositioning in Alzheimer rsquo s disease. Frontiers in Bioscience, 7(1), 184-188.
Corbett A, Williams G, Ballard C (2015). Drug repositioning in Alzheimer's disease. Front Biosci (Schol Ed), 7(1), 184-188. Abstract.  Author URL.
Creese B, Corbett A, DPhil EJ, Fox C, Ballard C (2015). Erratum to [Role of the Extended MAPT Haplotype in the Worsening of Psychotic Symptoms and Treatment Response in Alzheimer Disease, J Am Med Dir Assoc, 15, 12, (2014), 934-937], DOI: 10.1016/j.jamda.2014.08.011. Journal of the American Medical Directors Association, 16(3).
Ballard C, Isaacson S, Mills R, Williams H, Corbett A, Coate B, Pahwa R, Rascol O, Burn DJ (2015). Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People with Parkinson Disease Psychosis. J Am Med Dir Assoc, 16(10), 898.e1-898.e7. Abstract.  Author URL.
Corbett A, Owen A, Hampshire A, Grahn J, Stenton R, Dajani S, Burns A, Howard R, Williams N, Williams G, et al (2015). The Effect of an Online Cognitive Training Package in Healthy Older Adults: an Online Randomized Controlled Trial. Journal of the American Medical Directors Association, 16(11), 990-997.  Author URL.
Ballard C, Corbett A, Sharp S (2014). Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer’s disease. Expert Review of Neurotherapeutics, 11(3), 327-329.
Corbett A, Achterberg W, Husebo B, Lobbezoo F, de Vet H, Kunz M, Strand L, Constantinou M, Tudose C, Kappesser J, et al (2014). An international road map to improve pain assessment in people with impaired cognition: the development of the Pain Assessment in Impaired Cognition (PAIC) meta-tool. BMC Neurol, 14 Abstract.  Author URL.
Sultana J, Chang CK, Hayes RD, Broadbent M, Stewart R, Corbett A, Ballard C (2014). Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. International Journal of Geriatric Psychiatry, 29(12), 1249-1254. Abstract.
Drageset J, Corbett A, Selbaek G, Husebo BS (2014). Cancer-related pain and symptoms among nursing home residents: a systematic review. J Pain Symptom Manage, 48(4), 699-710.e1. Abstract.  Author URL.
Khan Z, Corbett A, Ballard C (2014). Cognitive stimulation therapy: training, maintenance and implementation in clinical trials. Pragmat Obs Res, 5, 15-19. Abstract.  Author URL.
Husebo BS, Corbett A (2014). Dementia: Pain management in dementia--the value of proxy measures. Nat Rev Neurol, 10(6), 313-314.  Author URL.
Corbett A, Burns A, Ballard C (2014). Don't use antipsychotics routinely to treat agitation and aggression in people with dementia. BMJ, 349  Author URL.
Ballard C, Aarsland D, Francis P, Corbett A (2014). Erratum to: Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: Pathophysiology, clinical features, and pharmacological management (Drugs Aging (2013) 30, (603-611) DOI: 10.1007/s40266-013-0092-x). Drugs and Aging, 31(8).
Testad I, Corbett A, Aarsland D, Lexow KO, Fossey J, Woods B, Ballard C (2014). Erratum: the value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review (International Psychogeriatrics (2014) DOI; 10.1017/S1041610214000131)). International Psychogeriatrics, 26(7).
Sandvik RK, Selbaek G, Seifert R, Aarsland D, Ballard C, Corbett A, Husebo BS (2014). Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial. Eur J Pain, 18(10), 1490-1500. Abstract.  Author URL.
Broadstock M, Ballard C, Corbett A (2014). Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies. Expert Opin Pharmacother, 15(13), 1797-1810. Abstract.  Author URL.
Corbett A, Smith J, Ballard C (2014). New and emerging treatments for Alzheimer’s disease. Expert Review of Neurotherapeutics, 12(5), 535-543.
Broadstock M, Ballard C, Corbett A (2014). Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease. Expert Rev Clin Pharmacol, 7(6), 779-786. Abstract.  Author URL.
Lichtner V, Dowding D, Esterhuizen P, Closs SJ, Long AF, Corbett A, Briggs M (2014). Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools. BMC Geriatr, 14 Abstract.  Author URL.
Cummings J, Isaacson S, Mills R, Williams H, Chi-Burris K, Corbett A, Dhall R, Ballard C (2014). Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet, 383(9916), 533-540. Abstract.  Author URL.
Ballard C, Corbett A, Howard R (2014). Prescription of antipsychotics in people with dementia. Br J Psychiatry, 205(1), 4-5.  Author URL.
Ballard C, Francis P, Corbett A (2014). Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies - ADDENDUM. Int Psychogeriatr  Author URL.
Creese B, Corbett A, Jones E, Fox C, Ballard C (2014). Role of the Extended MAPT Haplotype in the Worsening of Psychotic Symptoms and Treatment Response in Alzheimer Disease. Journal of the American Medical Directors Association, 15(12), 934-937.
Ballard C, Corbett A (2014). Screening for dementia: an opportunity for debate. Expert Review of Neurotherapeutics, 11(10), 1347-1349.
Fossey J, Masson S, Stafford J, Lawrence V, Corbett A, Ballard C (2014). The disconnect between evidence and practice: a systematic review of person-centred interventions and training manuals for care home staff working with people with dementia. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 29(8), 797-807.  Author URL.
Corbett A, Husebo BS, Achterberg WP, Aarsland D, Erdal A, Flo E (2014). The importance of pain management in older people with dementia. Br Med Bull, 111(1), 139-148. Abstract.  Author URL.
Testad I, Corbett A, Aarsland D, Lexow KO, Fossey J, Woods B, Ballard C (2014). The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review. INTERNATIONAL PSYCHOGERIATRICS, 26(7), 1083-1098.  Author URL.
Corbett A, Ballard C (2014). The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs. Evidence Based Medicine, 19(4), 140-140.
Ballard C, Corbett A (2013). Agitation and aggression in people with Alzheimer's disease. Current Opinion in Psychiatry, 26(3), 252-259.
Corbett A, Nunez K, Thomas A (2013). Coping with dementia in care homes. Maturitas, 76(1), 3-4.
Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, Ballard C (2013). Correction: Assessment and treatment of pain in people with dementia. Nature Reviews Neurology, 9(7), 358-358.
Ballard C, Jones E, Gauge N, Aarsland D, Nilsen OB, Saxby BK, Lowery D, Corbett A, Wesnes K, Katsaiti E, et al (2013). Correction: Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial. PLoS ONE, 8(9).
Corbett A, Williams G, Ballard C (2013). Drug Repositioning: an Opportunity to Develop Novel Treatments for Alzheimer’s Disease. Pharmaceuticals, 6(10), 1304-1321.
Corbett A, Smith J, Ballard C (2013). Erratum: New and emerging treatments for Alzheimer's disease (Expert Review of Neurotherapeutics (2012) 12:5 (533-543) DOI: 10.1586/ern.12.43). Expert Review of Neurotherapeutics, 13(7).
Corbett A, Smith J, Ballard C (2013). Erratum: New and emerging treatments for Alzheimer's disease (Expert Review of Neurotherapeutics (2012) 12:5 (535-543)). Expert Review of Neurotherapeutics, 13(6).
Clare L, Bayer A, Burns A, Corbett A, Jones R, Knapp M, Kopelman M, Kudlicka A, Leroi I, Oyebode J, et al (2013). Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT). Trials, 14 Abstract.  Author URL.
Corbett A, Ballard C (2013). Is a potential Alzheimer's therapy already in use for other conditions? can medications for hypertension, diabetes and acne help with the symptoms?. Expert Opinion on Investigational Drugs, 22(8), 941-943.
Ballard C, Aarsland D, Francis P, Corbett A (2013). Neuropsychiatric Symptoms in Patients with Dementias Associated with Cortical Lewy Bodies: Pathophysiology, Clinical Features, and Pharmacological Management. Drugs & Aging, 30(8), 603-611.
Corbett A, Smith J, Ballard C (2013). New and emerging treatments for Alzheimer's disease (vol 12, pg 535, 2012). EXPERT REVIEW OF NEUROTHERAPEUTICS, 13(6), 734-734.  Author URL.
Corbett A, Smith J, Ballard C (2013). New and emerging treatments for Alzheimer's disease (vol 12, pg 535, 2012). EXPERT REVIEW OF NEUROTHERAPEUTICS, 13(7), 871-871.  Author URL.
Achterberg W, Pieper MJC, van Dalen-Kok AH, de Waal MWM, Husebo BS, Lautenbacher S, Kunz M, Scherder EJA, Corbett A (2013). Pain management in patients with dementia. Clinical Interventions in Aging, 1471-1471.
Ballard C, Corbett A (2013). Randomised controlled trial: a small proportion of people with dementia and neuropsychiatric symptoms experience clinically significant worsening when antidepressants are discontinued (Evidence-Based Medicine (2013) 18, (27-28)). Evidence-Based Medicine, 18(3).
Ballard C, Francis P, Corbett A (2013). Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies. International Psychogeriatrics, 25(5), 687-689. Abstract.
Corbett A, Francis P, Ballard C (2013). Safety and efficacy of memantine extended-release in the management of alzheimer's disease. Clinical Medicine Insights: Therapeutics, 5, 95-102. Abstract.
Ballard C, Corbett A (2012). A small proportion of people with dementia and neuropsychiatric symptoms experience clinically significant worsening when antidepressants are discontinued. Evidence Based Medicine, 18(1), 27-28.
Corbett A, Ballard C (2012). Antipsychotics and Mortality in Dementia. American Journal of Psychiatry, 169(1), 7-9.
Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, Ballard C (2012). Assessment and treatment of pain in people with dementia. Nature Reviews Neurology, 8(5), 264-274. Abstract.
(2012). Correction: Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial. PloS one, 7(9).
Corbett A, Husebo B, Ballard C (2012). Discomfort in dementia: identifying and managing pain. Nursing and Residential Care, 14(9), 462-467.
Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, Hagan JJ, Holmes C, Jones E, Katona C, et al (2012). Drug repositioning for Alzheimer's disease. Nature Reviews Drug Discovery, 11(11), 833-846.
Corbett A, Burns A, Ballard C (2012). F4‐02‐04: Management of behavioural and psychological symptoms of dementia: Development of a best practice guide. Alzheimer's & Dementia, 8(4S_Part_17), p609-p609.
Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu L-M, Tyrer S, Francis PT, et al (2012). Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. LANCET, 379(9815), 528-536.  Author URL.
Corbett A, Ballard C (2012). New and emerging treatments for Alzheimer's disease. Expert Opin Emerg Drugs, 17(2), 147-156. Abstract.  Author URL.
Ballard C, Corbett A (2012). New guidelines on disorders associated with dementia. Nature Reviews Neurology, 8(12), 663-664.
Ballard C, Jones E, Gauge N, Aarsland D, Nilsen OB, Saxby BK, Lowery D, Corbett A, Wesnes K, Katsaiti E, et al (2012). Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial. PLoS ONE, 7(6), e37410-e37410.
Corbett A, Smith J, Creese B, Ballard C (2012). Treatment of Behavioral and Psychological Symptoms of Alzheimer’s Disease. Current Treatment Options in Neurology, 14(2), 113-125.
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011). Alzheimer's disease. LANCET, 377(9770), 1019-1031.  Author URL.
Creese B, Ballard C, Corbett A, Aarsland D (2011). Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality. Expert Opinion on Drug Safety, 10, 35-43.
Ballard C, Corbett A, Jones EL (2011). Dementia: challenges and promising developments. The Lancet Neurology, 10(1), 7-9.
Ballard C, Corbett A, Pickett J (2011). Depression and dementia. Ment Health Today, 23-25.  Author URL.
Talà A, Monaco C, Nagorska K, Exley RM, Corbett A, Zychlinsky A, Alifano P, Tang CM (2011). Glutamate utilization promotes meningococcal survival <i>in vivo</i> through avoidance of the neutrophil oxidative burst. Molecular Microbiology, 81(5), 1330-1342. Abstract.
Corbett A, Ballard C (2011). Information provision services in dementia care. International Journal of Older People Nursing, 6(3), 217-226. Abstract.
Ballard C, Khan Z, Clack H, Corbett A (2011). Nonpharmacological treatment of Alzheimer disease. Can J Psychiatry, 56(10), 589-595. Abstract.  Author URL.
Corbett A, Stevens J, Aarsland D, Day S, Moniz‐Cook E, Woods R, Brooker D, Ballard C (2011). Systematic review of services providing information and/or advice to people with dementia and/or their caregivers. International Journal of Geriatric Psychiatry, 27(6), 628-636. Abstract.
Ballard C, Smith J, Husebo B, Aarsland D, Corbett A (2011). The role of pain treatment in managing the behavioural and psychological symptoms of dementia (BPSD). Int J Palliat Nurs, 17(9), 420-424.  Author URL.
Ballard C, Kahn Z, Corbett A (2011). Treatment of dementia with Lewy bodies and Parkinson's disease dementia. Drugs Aging, 28(10), 769-777. Abstract.  Author URL.
Ballard C, Corbett A (2010). Management of neuropsychiatric symptoms in people with dementia. CNS Drugs, 24(9), 729-739. Abstract.  Author URL.
Ballard CG, Corbett A, Clack H, Owen A (2010). P4‐113: can Brain Training Games Improve Cognition in Peope over 60?. Alzheimer's & Dementia, 6(4S_Part_21), e55-e56.
Ballard C, Corbett A, Chitramohan R, Aarsland D (2009). Management of agitation and aggression associated with Alzheimerʼs disease: controversies and possible solutions. Current Opinion in Psychiatry, 22(6), 532-540.
Carpenter EP, Corbett A, Thomson H, Adacha J, Jensen K, Bergeron J, Kasampalidis I, Exley R, Winterbotham M, Tang C, et al (2007). AP endonuclease paralogues with distinct activities in DNA repair and bacterial pathogenesis. The EMBO Journal, 26(5), 1363-1372.
Corbett A, Exley R, Bourdoulous S, Tang CM (2004). Interactions between <i>Neisseria meningitidis</i> and human cells that promote colonisation and disease. Expert Reviews in Molecular Medicine, 6(14), 1-14. Abstract.

Chapters

Corbett A, Ballard C, Creese BA (2018). Evidence-based management of behavioural and psychological symptoms of dementia. In Michel J-P, Beattie BL, Martin FC, Walston JD (Eds.) Oxford Textbook of Geriatric Medicine, Oxford University Press, 1015-1020. Abstract.
Ballard C, Corbett A (2012). Management of agitation and aggression: Controversies and possible solutions. In  (Ed) Advances in Alzheimer's Disease Management, 69-79.
Ballard C, Corbett A (2012). Management of agitation and aggression: controversies and possible solutions. In  (Ed) Advances in Alzheimer’s Disease Management, Future Science Group, 68-79.

Conferences

Ritchie S, Lawrence V, Jones J, Corbett A (2022). 676 OPTIMISING ENGAGEMENT OF OLDER ADULTS IN AN ONLINE PHYSICAL ACTIVITY PROGRAMME TO IMPROVE COGNITION: a QUALITATIVE STUDY.  Author URL.
Arathimos R, Fabbri C, Vassos E, Davis K, Pain O, Gillett A, Coleman J, Hanscombe KB, Hagenaars S, Jermy B, et al (2021). LATENT SUBTYPES OF MANIC OR IRRITABLE EPISODE SYMPTOMS IN TWO POPULATION-BASED COHORTS.  Author URL.
Ballard C, Allan L, Corbett A, Creese B, Brooker H, Fox C, Sami S, Shepstone L, Khondoker M, Richardson K, et al (2019). Interaction of Biological and Psychosocial Factors in Dementia.  Author URL.
Drageset J, Eide GE, Corbett A (2017). Patterns of health-related quality of life among nursing home residents with and without cancer.  Author URL.
Dowding D, Lichtner V, Esterhuizen P, Closs SJ, Long A, Corbett A, Briggs M (2015). Pain Assessment Tools for Individuals with Dementia: a Metareview.  Author URL.
Ballard C, Mills R, Williams H, Corbett A, Cummings J (2014). TREATMENT OF PSYCHOSIS IN PARKINSON'S DISEASE AND PARKINSON'S DISEASE DEMENTIA.  Author URL.

Back to top

External Engagement and Impact

Media Coverage

Anne is fully media trained and has appeared on several media channels including television, radio and print. This has included BBC News, Sky News, ITV News, Channel 4 News, BBC Radio 4 Today Programme, Regional BBC Radio and a wide selection of print media. A selection is provided below:

Back to top

Teaching

University Teaching Framework

My teaching focusses on supporting students to develop their skills, knowledge and experience in research fields related to their field of study. This includes:

- Hosting a cohort of Final Year Medical Science students to complete Research Projects utilising data from our PROTECT study

- Hosting a Special Study Unit on cognitive health research for Third Year Medical students

- Supporting critical appraisal and literature review modules across the year groups and College disciplines

I am also an Academic Tutor for a group of current Year 1 Neuroscience students

Supporting Professional Development

Beyond the University teaching framework I have also dedicated time to teaching and training in key settings to embed knowledge and understanding about cognitive health and dementia care. These activities include:

- Authoring a Best Practice Guideline for management of behavioural symptoms in dementia, which is in use across the workd and translated into eight languages

- Delivering training on the best practice guide described above to GP and care staff groups

- Co-creating and delivering training in a tool to reduce placebo response in trials of behavioural symptoms in people with neurodegernative diseases

Finally, I have delivered seminars and workshops to students and researchers on Science Communication and Dissemination in the UK, US and Norway.

Back to top

Supervision / Group

Postgraduate researchers

  • Jon Arild Aakre
  • H Brooker
  • Susanne Dyson
  • Nicholas Luscombe
  • Jessica Rundle

Back to top

Office Hours:

Monday, Tuesday, Thursday and Friday 

Back to top

Edit Profile